Background {#Sec1}
==========

Migraine attacks consist of a complex sequence of symptoms. In the prodromal phase, vegetative symptoms like hunger, sleepiness and orthostatic hypotension are reported. Later, in the headache phase, vomiting and nausea are typical vegetative symptoms. These symptoms illustrate the strong relationship between migraine and the function of the autonomic nervous system \[[@CR1]\]. Furthermore, recently it was reported that transcutaneous stimulation of the parasympathetic nerve system via the vagus nerve can abort migraine attacks \[[@CR2]\].

Besides the influence of parasympathetic activity on migraine, there are also several observations which underline the importance of sympathetic activity for migraine triggering. Patients often report that sleep deficits, skipping a meal or stressful situations can trigger their migraine attacks \[[@CR3], [@CR4]\]. An increased basal sympathetic tone is also suggested by the fact that migraine is associated with more frequent history of hypertension in epidemiological investigations \[[@CR5]\]. Hypertension may be a result of a lasting sympathetic activation \[[@CR6]\]. However, other studies have found increased diastolic but not systolic blood pressure in migraine \[[@CR7]\] or even an association of migraine with lower blood pressure \[[@CR6], [@CR8]\], so the exact relationship between migraine and blood pressure is not clear yet.

Though, research directly trying to quantify abnormalities of the autonomic nervous system in migraine patients delivered quite contradictory results. Besides sympathetic hypofunction \[[@CR9]\] or, on the other hand, increased sympathetic activation \[[@CR10]\], studies also reported parasympathetic hypofunction \[[@CR11]\] or hyperfunction \[[@CR12]\].

A possible reason for these striking differences might be that many studies did not define the time point of measurement in relation to the previous or next migraine attack, since migraine seems to involve endogenous rhythms which may also influence the autonomic nervous system \[[@CR13], [@CR14]\]. In addition, most studies did not use specific stimulation of autonomic responses. Therefore we decided to measure heart rate variability and skin conductance responses during parasympathetic activation (paced breathing) and sympathetic activation (mental stress) in migraine patients during the interictal period (no migraine for 48 hours before and after the measurement) and controls. In addition we assessed blood pressure and heart rate once daily for 2 weeks.

Methods {#Sec2}
=======

Subjects {#Sec3}
--------

Twenty-five controls and 25 episodic migraine patients without aura were recruited using advertisements on the hospital and university campus and via the internet. Migraine, and the absence of other headache types (e.g. tension type headache), was diagnosed according to the International Classification of Headache Disorders (ICHD-III) \[[@CR15]\] by an experienced physician from the outpatient headache clinic at the Department of Neurology. Healthy participants had to be free of any headaches. In addition, migraine participants had to be free of any preventive medication for at least 4 weeks prior to the experiment. Migraine patients were tested interictally, meaning they were free of headache for at least 48 hours before and after the experimental session which was confirmed by a diary and a telephone call 48 h after the recordings. Analgesics and triptans were not allowed within 48 hours before and after the experiment. Participants were asked not to consume alcohol or caffeinated drinks for 3 hours prior to the experiment. Since three migraine patients developed headache within 48 hours after the experimental session and therefore had to be excluded from analysis, only 22 migraine patients (age 28.1 ± 6.9; male/female 1:21) and 25 controls (age 26.1 ± 7.1; male/female 3:22) could be analyzed. Demographic data is given in Table [1](#Tab1){ref-type="table"}. The study was approved by the local ethics committee and conducted in accordance with the Declaration of Helsinki. Subjects provided written informed consent before participation.Table 1Characteristics of the subjectsMigraineControln2225Age28.1 ± 6.926.1 ± 7.1Gender (male:female)1:213:22Headache history (years)10.7 ± 6.1Headache days/month4.9 ± 2.2Headache intensity (1-10)6.8 ± 1.3All migraine patients suffered from episodic migraine without aura. Values are mean ± SD

Experimental design and data acquisition {#Sec4}
----------------------------------------

The electrocardiogram (ECG), skin conductance and respiratory excursions were measured using the SUEmpathy100 system (SUESS Medizin-Technik GmbH, Mittelstraße 9, 08280 Aue, Germany). The ECG was recorded with a sampling rate of 512 Hz using three electrodes (Ag/AgCl), attached over the medioclavicular line over the first intercostal space (left and right) and over the anterior axillar line over the fifth left intercostal space. Respiratory excursions were obtained by a sensor attached to the inferior aperture of the thorax (only during the paced breathing test, see below). Skin conductance response was measured using Ag/AgCl electrodes attached to the second and third finger of the left hand (only during the mental stress test, see below).

Data were obtained with patients in a relaxed supine position in a silent and darkened room. The room was kept at a constant temperature of 22 °C ± 2 °C. Two experiments were always conducted at the same time in the early evening. The first experiment (paced breathing test) consisted of a five-minute baseline, followed by two minutes of paced breathing (6 breathing cycles per minute, paced by standardized, pre-recorded instructions administered via earphones) and a five-minute recovery phase. The second experiment (mental stress test) consisted of a five-minute baseline, followed by one minute of anticipation, three and a half minutes of mental stress and a five-minute recovery phase. During the anticipation phase, subjects were told that the stress test would be an arithmetic test requiring them to repeatedly subtract the same two-digit number from a four-digit number (e.g. 1750--13) as fast as possible. During the mental stress phase, subjects performed the task under the surveillance of the investigator.

In the 2 weeks preceding or following the experimental session, subjects measured their blood pressure and heart rate daily (in the morning, after waking up) using an Omron M500 blood pressure monitor (Omron Healthcare Europe B.V., Scorpius 33, 2132 LR Hoofddorp, P.O.Box 2050 2130 GL Hoofddorp, Netherlands). A headache diary was kept during this time.

Data on headache history, number of headache days/month, headache intensity and average stress levels during the preceding 24 hours (quantified on a numerical rating scale from 0--10, where 0 = no stress at all and 10 = most intense stress imaginable) were obtained by a clinical interview. Stress levels were also obtained after each experiment, with respect to the stress levels reached during the mental stress test and during the paced breathing test. We opted for a single self-rating item to assess stress levels because single-item measures are timesaving, easily understandable and have recently demonstrated good reliability and validity \[[@CR16]\]. Stress levels were measured on the numerical rating scale (NRS) which is conceptionally similar to the visual analogue scale (VAS) that has recently been validated to assess perceived stress in occupational medicine \[[@CR17]\].

Data analysis {#Sec5}
-------------

The SUEmpathy100 system automatically analyses the ECG recording during the different experimental phases, providing data on the average heart rate (HR), the coefficient of variation (CV) of the interval between two subsequent R waves (RR interval) as a measure of overall heart rate variability, the root mean square of successive differences in RR intervals (RMSSD) as a measure of short-term heart rate variability, the power spectrum of the heart rate variability in three different frequency bands (very low frequency \[VLF\]: 0.0033--0.04 Hz, corresponding to predominantly sympathetically mediated activity; low frequency \[LF\]: 0.04--0.15 Hz, reflecting a mixture of both sympathetic and parasympathetic activity; and high frequency \[HF\]: 0.15--0.4Hz, corresponding to predominantly parasympathetically mediated activity), and the LF/HF ratio as a measure of sympathetic in relation to parasympathetic activity \[[@CR18]\]. After each experiment, ECG traces were manually revised to ensure that the R-waves had been correctly detected by the in-built algorithm. Where the algorithm had failed, R wave detection was corrected manually. Then, data on the parameters listed above and on the skin conductance response (sampling rate: 512 Hz) were exported to Excel for further analysis. To determine the expiration/inspiration ratio of RR intervals during the paced breathing phase, maximum RR intervals during expiration and minimum RR intervals during inspiration were detected during each breathing cycle, averaged over all breathing cycles obtained and the expiration/inspiration ratio was calculated. To analyze the influence of mental stress on skin conductance responses, the average skin conductance response during each experimental phase was calculated and the average skin conductance level during the last minute of the baseline phase was subtracted from this value.

Statistical analysis {#Sec6}
--------------------

Data were analyzed using the Statistical Package for Social Sciences (SPSS, version 22, IBM Corporation, Armonk, New York, USA). Values are given as mean ± standard deviation (SD) unless otherwise stated. *P* \< 0.05 was considered significant. Age and sex were compared between groups using a *t*-test and a chi-square test respectively. The experimental parameters (heart rate, different parameters of the time and frequency domain heart rate analysis, skin conductance responses) were compared between groups using repeated measures ANOVA (within-subject factor: different phases of the two tests \[for paced breathing: baseline, paced breathing, and recovery; and for mental stress: baseline, anticipation, stress, and recovery\], between-subject factor: group) and t-tests as appropriate. Stress ratings were compared between groups using repeated measures ANOVA (within subject factor: reference \[average, paced breathing, mental stress\], between subjects factor: group). Average blood pressure and heart rates obtained over 2 weeks were compared between groups using unpaired t-tests. Blood pressure and heart rates between headache days and interictal days in migraine patients were compared using paired t-tests.

Results {#Sec7}
=======

Subjects {#Sec8}
--------

Age and sex were balanced between groups (see Table [1](#Tab1){ref-type="table"}) (age: T \[45\] = -1.0, *p* = 0.32, sex: *χ*2\[1\] = 0.8, *p* = 0.36).

### Blood pressure and heart rate (2 week average) {#Sec9}

Average blood pressure and heart rate, derived from daily measurements over 2 weeks are shown in Table [2](#Tab2){ref-type="table"} together with corresponding statistics. Unpaired t-tests showed no significant differences in systolic or diastolic blood pressure (*p* = 0.43). However, average heart rate was slightly but significantly elevated in migraine patients as compared to controls (75.5 bpm in migraine patients and 70.9 bpm in controls, *p* = 0.03), in agreement with the idea of higher sympathetic and/or lower parasympathetic activity in migraine patients as compared to controls. During the two weeks of blood pressure and heart rate measurement, migraine patients suffered from headache for on average 2.55 ± 1.77 days. We tested if blood pressure and/or heart rate were different on headache days, compared to interictal days, but there were no significant differences. (BP systolic : mean ± SD: ictal = 111.4 ± 9.2, interictal = 111.6 ± 8.9; T \[19\] = -0.19, *p* = 0.85; BP diastolic: mean ± SD: ictal = 73.4 ± 12.3, interictal = 72.8 ± 8.0; T \[19\] = 0.42, *p* = 0.68; HR : mean ± SD: ictal = 76.5 ± 9.8, interictal = 75.1 ± 8.1; T \[19\] = 0.96, *p* = 0.35).Table 2Average blood pressure and heart rate over 2 weeksParameterMigraine (n = 22) Mean ± SDControl (n =25) Mean ± SDGroup comparisonBP \[mmHg\]Systolic blood pressure112.53 ± 10.68116.79 ± 10.15T \[45\] = 1.4 *p* = 0.17Diastolic blood pressure72.76 ± 6.9871.14 ± 6.78T \[45\] = -0.8 *p* = 0.43HR \[bpm\]75.51 ± 7.4270.85 ± 6.64T \[45\] = -2.3 *p* = 0.03Values are mean ± SD. *BP* blood pressure, *HR* heart rate, Results of unpaired t-tests are given

### Stress ratings {#Sec10}

Subjective stress ratings were obtained with reference to average stress levels (during the 24 hours preceding measurement), and stress levels during the mental stress and the paced breathing conditions (see Table [3](#Tab3){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"}). There was a main effect of group (*p* = 0.029), indicating elevated subjective stress ratings in migraine patients compared to controls in all conditions, but no significant interaction between condition and group (*p* = 0.47, see Table [3](#Tab3){ref-type="table"} for statistics).Table 3Comparison of stress ratings between controls and migraine patientsParameterMigraine (*n* = 22) Mean ± SDControl (*n* =25) Mean ± SDMain effect of blockMain effect of groupInteractionStress ratings \[0-10\]Average during preceding 24 h3.27 ± 2.252.36 ± 2.04F \[2,44\] = 103.7 *p* \< 0.001F \[1\] = 5.1 *p* = 0.029F \[2,44\] = 0.8 *p* = 0.47During paced breathing1.09 ± 1.510.56 ± 0.96During mental stress5.41 ± 1.974.20 ± 1.85Values are mean ± SD. Results of ANOVA are givenFig. 1Stress self-ratings average stress level, during the paced breathing and during the mental stress test. Ratings for interictal migraine patients (*n* = 22) and controls (*n* = 25) are illustrated as mean ± SEM. The y-axis illustrates the stress rating scale (0-10)

### Heart rate analysis during the paced breathing test {#Sec11}

Results of heart rate and heart rate variability parameters during the paced breathing test in controls and migraine patients are summarized in Table [4](#Tab4){ref-type="table"} together with the corresponding statistics. RMSSD (root mean square of successive differences) and heart rate profiles during the paced breathing test are illustrated in Fig. [2](#Fig2){ref-type="fig"} ([a1](#Fig2){ref-type="fig"} and [b1](#Fig2){ref-type="fig"}). Average heart rate (*p* = 0.014) and all heart rate variability parameters (VC: *p* \< 0.001, VLF power: *p* \< 0.001, LF power: *p* \< 0.001, HF power: *p* = 0.003, LF/HF: *p* \< 0.001), with the exception of the RMSSD (*p* = 0.89), showed a main effect of block, indicating that paced breathing had a significant effect on these parameters. There was no significant main effect of group (VC: *p* = 0.60, RMSSD: *p* = 0.56, VLF power: *p* = 0.85, LF power: *p* = 0.98, HF power: *p* = 0.78, LF/HF: *p* = 0.92) and no significant interaction between block and group for any of the parameters. However, when looking at the raw values in Table [4](#Tab4){ref-type="table"}, it becomes clear that migraine patients show a slightly (statistically non-significant) higher sympathetic and/or lower parasympathetic tone for all parameters investigated (smaller VC and RMSSD, increased VLF power, reduced HF power, increased heart rate). A trend of significance (*p* = 0.09) was found for heart rate. Consistent with the finding in the 2-week heart rate averages described above, heart rate was again higher in migraine patients. E/I ratio (ratio of the heart rates during inspiration and expiration) was assessed only during the paced breathing block and did not differ between the groups (*p* = 0.82).Table 4Comparison of heart rate and heart rate variability parameters during the paced breathing test between controls and migraine patientsParameterBlockMigraine (n = 22) Mean ± SDControl (n =25) Mean ± SDMain effect of blockMain effect of groupInteraction block\*groupVC \[%\]Baseline8.69 ± 4.859.10 ± 3.83**F \[2,44\] = 27.7** ***p*** ** \< 0.001**F \[1\] = 0.3 *p* = 0.60F \[2,44\] = 0.2 *p* = 0.83Paced breathing11.46 ± 5.1012.37 ± 3.84Recovery8.83 ± 4.739.42 ± 3.55RMSSD \[ms\]Baseline86.27 ± 69.6996.07 ± 65.66F \[2,44\] = 0.113 *p* = 0.89F \[1\] = 0.4 *p* = 0.56F \[2,44\] = 0.4 *p* = 0.69Paced breathing82.75 ± 57.2597.71 ± 60.28Recovery85.84 ± 70.8393.86 ± 66.38VLF power \[ms^2^\]Baseline77 ± 11172 ± 83**F \[2,44\] = 25.6** ***p*** ** \< 0.001**F \[1\] = 0.04 *p* = 0.85F \[2,44\] = 0.06 *p* = 0.94Paced breathing215 ± 235200 ± 134Recovery78 ± 10978 ± 77LF power \[ms^2^\]Baseline3450 ± 40113467 ± 3738**F \[2,44\] = 25.7** ***p*** ** \< 0.001**F \[1\] = 0.001 *p* = 0.98F \[2,44\] = 0.06 *p* = 0.94Paced breathing10354 ± 991610600 ± 6637Recovery4369 ± 54544215 ± 3937HF power \[ms^2^\]Baseline4252 ± 78224457 ± 6130**F \[2,44\] = 6.6** ***p*** ** = 0.003**F \[1\] = 0.08 *p* = 0.78F \[2,44\] = 0.3 *p* = 0.77Paced breathing2043 ± 33782296 ± 3335Recovery3323 ± 57544166 ± 6971LF/HFBaseline1.46 ± 1.351.43 ± 1.19**F \[2,44\] = 25.1** ***p*** ** \< 0.001**F \[1\] = 0.01 *p* = 0.92F \[2,44\] = 1.3 *p* = 0.29Paced breathing13.58 ± 14.1113.46 ± 11.49Recovery1.81 ± 1.572.36 ± 2.40E/IPaced breathing1.37 ± 0.201.38 ± 0.17-T \[44\] = 0.2 p = 0.82-HR \[bpm\]Baseline65.86 ± 7.4562.28 ± 8.34**F \[2,44\] = 4.7** ***p*** ** = 0.014**F \[1\] = 3.1 *p* = 0.09F \[2,44\] = 0.6 *p* = 0.58Paced breathing67.12 ± 7.0062.77 ± 8.27Recovery65.84 ± 7.1561.91 ± 8.39Values are mean ± SD. *VC* Coefficient of variation in percent (SD/RR\*100), RMSSD: root mean square of successive differences = root mean square of the sum of squares of differences between adjacent RR (normalized R-to-R) intervals, *VLF* power in the very low frequency band (0.0033--0.04Hz), *LF* power in the low frequency band (0.04--0.15Hz), *HF* power in the high frequency band (0.15--0.4Hz), LF/HF: ratio of LF to HF, *E/I*: heart rate ratio between expiration and inspiration, *HR* heart rate. Results of ANOVA and unpaired t-tests are given. Significant effects are marked in bold. There were no significant group differencesFig. 2Group differences of cardiovascular parameters during paced breathing and mental stress test between controls and migraine patients. A RMSSD (*root mean square of successive differences*) and B HR (*heart rate*) profiles are illustrated interictally for migraine patients (*n* = 22) and controls (*n* = 25) as mean ± SEM. **a1** RMSSD during the paced breathing test. **a2** RMSSD during the mental stress test. **b1**Heart rate (*HR*) during the paced breathing test. **b2** HR during the mental stress test

### Heart rate analysis during the mental stress conditions {#Sec12}

Heart rates and heart rate variability during the mental stress test were measured and are reported in Table [5](#Tab5){ref-type="table"} together with corresponding statistics. RMSSD and heart rate profiles during the mental stress test are illustrated in Fig. [2](#Fig2){ref-type="fig"} ([a2](#Fig2){ref-type="fig"} and [b2](#Fig2){ref-type="fig"}). Again, heart rate and all heart rate variability parameters showed a main effect of block (see Table [5](#Tab5){ref-type="table"}, VC: *p* = 0.015, RMSSD: *p* = 0.019, VLF power: *p* = 0.017, LF power: *p* = 0.023, HF power: *p* = 0.006, LF/HF: *p* = 0.033, HR: *p* \< 0.001), indicating that the mental stress paradigm did indeed significantly affect these parameters. But no significant main effect of group (VC: p = 0.49, RMSSD: p = 0.57, VLF power: *p* = 0.61, LF power: *p* = 0.84, HF power: *p* = 0.21, LF/HF: *p* = 0.65, HR: *p* = 0.15) and no significant interaction between block and group were found for all parameters during the mental stress test. Again, the majority of parameters (VC, RMSSD, HF power, and HR) showed a slightly (but non-significant) stronger sympathetic activation and/or parasympathetic hypofunction in migraine patients compared to controls.Table 5Comparison of heart rate, heart rate variability and skin conductance level parameters during the mental stress test between controls and migraine patientsParameterPhaseMigraine (n = 22) Mean ± SDControl (n =25) Mean ± SDMain effect of blockMain effect of groupInteractionVC \[%\]Baseline8.35 ± 3.998.80 ± 3.59**F \[3,43\] = 3.9** ***p*** ** = 0.015**F \[1\] = 0.5 *p* = 0.49F \[3,43\] = 1.1 *p* = 0.37Anticipation8.53 ± 3.4110.20 ± 3.84Stress9.41 ± 6.139.44 ± 3.98Recovery9.50 ± 4.1610.36 ± 5.78RMSSD \[ms\]Baseline77.03 ± 56.3987.01 ± 49.41**F \[3,43\] = 3.7** ***p*** ** = 0.019**F \[1\] = 0.3 *p* = 0.57F \[3,43\] = 0.8 *p* = 0.52Anticipation58.77 ± 39.4572.35 ± 47.23Stress65.31 ± 68.4458.76 ± 34.66Recovery76.16 ± 49.8687.65 ± 59.97VLF power \[ms^2^\]Baseline58 ± 8562 ± 69**F \[3,43\] = 3.8** ***p*** ** = 0.017**F \[1\] = 0.3 *p* = 0.61F \[3,43\] = 1.1 *p* = 0.35Anticipation24 ± 2744 ± 44Stress33 ± 3435 ± 39Recovery65 ± 8868 ± 63LF power \[ms^2^\]Baseline3496 ± 47223126 ± 3192**F \[3,43\] = 3.5** ***p*** ** = 0.023**F \[1\] = 0.04 *p* = 0.84F \[3,43\] = 1.5 *p* = 0.22Anticipation1802 ± 19782889 ± 2512Stress2239 ± 21722293 ± 2001Recovery3865 ± 48133720 ± 3062HF power \[ms^2^\]Baseline2241 ± 26113645 ± 4606**F \[3,43\] = 4.8** ***p*** ** = 0.006**F \[1\] = 1.6 *p* = 0.21F \[3,43\] = 1.6 *p* = 0.21Anticipation1021 ± 10491595 ± 1663Stress981 ± 9761632 ± 2213Recovery2397 ± 27743133 ± 4121LF/HF \[Hz\]Baseline1.74 ± 1.181.73 ± 1.93**F \[3,43\] = 3.2** ***p*** ** = 0.033**F \[1\] = 0.2 p = 0.65F \[3,43\] = 1.2 p = 0.34Anticipation2.55 ± 1.802.64 ± 1.77Stress2.91 ± 1.972.10 ± 1.19Recovery2.04 ± 1.412.12 ± 1.77HR \[bpm\]Baseline67.83 ± 11.5162.10 ± 8.48**F \[3,43\] = 58.9** ***p*** ** \< 0.001**F \[1\] = 2.2 *p* = 0.15F \[3,43\] = 1.3 *p* = 0.30Anticipation74.23 ± 10.3070.31 ± 9.94Stress76.86 ± 9.8373.72 ± 10.00Recovery67.36 ± 6.8864.93 ± 8.05SCR \[μS\]Anticipation2.72 ± 2.532.38 ± 2.50**F \[3,43\] = 32.5** ***p*** ** \< 0.001**F \[1\] = 0.2 *p* = 0.70F \[3,43\] = 0.2 *p* = 0.91Stress5.43 ± 3.724.98 ± 3.28Recovery2.40 ± 1.832.38 ± 1.87Values are mean ± SD. *VC* Coefficient of variation in percent (SD/RR\*100), RMSSD: root mean square of successive differences = root mean square of the sum of squares of differences between adjacent RR (normalized R-to-R) intervals, VLF power in the very low frequency band (0.0033--0.04Hz), LF: power in the low frequency band (0.04-0.15Hz), HF: power in the high frequency band (0.15--0.4Hz), LF/HF ratio of LF to HF, HR: heart rate, SCR: average skin conductance response in each phase. Results of ANOVA and unpaired t-tests are given. Significant effects are marked in bold. There were no significant group differences

Skin conductance {#Sec13}
----------------

The skin conductance responses were only assessed during the mental arithmetic test (Table [5](#Tab5){ref-type="table"} and Fig. [3](#Fig3){ref-type="fig"}). There was a main effect of block (*p* \< 0.001), but no main effect of group (*p* = 0.70), and no interaction between group and block (*p* = 0.91).Fig. 3Group differences in skin conductance latency (*SCL*) during the mental stress test. SCL profiles for interictal migraine patients (*n* = 22) and controls (*n* = 25) are illustrated as mean ± SEM. During the anticipation (*minute 5-6*) subjects were instructed what the stress test will be, followed by 2.5 minutes stress test

Discussion {#Sec14}
==========

The main result of our study assessing cardiac and cardiovascular parameters during experimental activation of the parasympathetic and sympathetic systems and during daily life over a period of 2 weeks is that there were no striking differences in these parameters between episodic migraine patients without aura and matched controls. However, there may be subtle differences as revealed by a significantly elevated average heart rate over 2 weeks, higher subjective stress ratings, and a trend towards increased heart rate during the paced breathing condition in migraine patients. It is worth discussing if these subtle findings indicate a slight shift to more sympathetic nervous system activity in migraine patients compared to controls.

There are a number of earlier studies dealing with autonomic nervous system activity in migraine. Overall, they do not present a clear picture of the possible alterations of the autonomic nervous system in migraine. There are a number of studies which postulate a sympathetic hyperfunction and/or a sympathetic hypofunction in migraine. Similar to our results, Gass and Glaros (2013) found a sympathetic hyperfunction in migraine patients \[[@CR10]\]. They analyzed heart rate variability, skin temperature, skin conductance, and respiration in 21 patients with tension-type and/or migraine headache and 19 controls during a 5-min resting period. There were no statistical differences in HRV measures in the frequency domain, or in skin temperature or skin conductance between the groups, but the number of consecutive R-to-R intervals that varied by more than 50 ms were significantly lower in the headache group than in the control group. They concluded that these results suggest increased sympathetic and/or decreased parasympathetic nervous system activity in headache. Yerdelen et al. examined heart rate recovery after physical exercise as an index for vagal activity in migraine and tension-type headache patients (TTH) and controls \[[@CR19]\]. Heart rate recovery was similar in all three groups, but resting heart rates in migraine were higher than in episodic TTH, albeit not significantly different from controls. This result is somewhat similar to our finding during the consecutive measurement for 2 weeks. They conclude that sympathetic tone in migraine patients is elevated compared to patients with episodic tension-type headache.

Similarly to our study, where there was a stronger group difference in subjective measures (stress levels) than objective measures, Tome-Pires et al. found only a trend for higher skin conductance responses for pain descriptors and emotional words in migraine patients compared to controls, but a higher recall of emotional words in the migraine group \[[@CR20]\].

Another study examined heart rate variability for a longer period. They recorded a forty-eight-hour Holter electrocardiogram in 27 migraine patients in the headache-free period and 24 healthy controls during normal daily activity. They found significant differences in circadian rhythm in different heart rate variability parameters between migraine patients and controls, pointing towards parasympathetic hypofunction in migraine patients \[[@CR11]\]. The study by Thomson and colleagues in which cardiovascular reflexes in response to the Valsalva manoeuvre were measured in migraine patients also pointed towards a parasympathetic hypofunction \[[@CR21]\].

Some studies also failed to find differences between migraine patients and controls, or signs of sympathetic hypofunction in migraine. For instance, no differences in heart rate, temporal artery pulse volume and skin conductance response between migraine patients and controls during self-selected 'stressful' and 'relaxing' imagery were found \[[@CR22]\]. Cambron et al. report evidence for a subtle pupillary sympathetic hypofunction in migraine patients, observed as a prolonged latency to light reflex, which is revealed after the administration of apraclonidine \[[@CR9]\].Similarly, resting supine sympathetic hypofunction as measured by heart rate variability parameters in migraine patients with aura was reported \[[@CR23]\].

In spite of the heterogeneity of the published results, the most often discussed interpretations concerning the alteration of autonomic functions in migraine patients in the literature are:a sympathetic hyperactivation and/ora parasympathetic hypoactivation.The present result that heart rates over 2 weeks are increased in migraine patients may support the hypothesis of increased sympathetic and/or impaired parasympathetic activity in migraine. Consistently, there was also a trend for higher heart rates in migraine patients during all phases of the paced breathing test (*p* = 0.09) and the mental stress test (0.15). Heart rate is regulated by both the sympathetic and the parasympathetic nervous system, so an increased heart rate in migraine patients could also be interpreted as an increased sympathetic tone or, alternatively, reduced parasympathetic activity. Moreover, when looking at the raw values, there was a slight shift towards less sympathetic and/or more parasympathetic activity for almost every parameter assessed (Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}), although this did not reach significance. For example, the RMSSD and the high-frequency band power, which are measures of parasympathetic activity, were consistently lower in migraine patients than in healthy controls during all phases of the paced breathing and mental stress tasks.

Furthermore, it was shown that migraine patients feel more stressed in all conditions tested (in general, during paced breathing and the mental stress test) .This confirms earlier findings that migraine patients tend to react towards environmental factors more and with a lower stimulus threshold \[[@CR24], [@CR25]\], possibly associated with a higher sympathetic tone. Such increased basic sympathetic activity may also account for the fact that in epidemiological population-based studies migraine patients tend to have a higher average blood pressure \[[@CR5]\].

Strengths and limitations of our study {#Sec15}
--------------------------------------

Certainly, the strength of our study is the careful selection and monitoring of the migraine patients, ensuring that all patients were recorded interictally and were free of preventive drugs or recent intake of analgesics. The migraine patients included in the present study had, on average, about 5 headache days per month (range: ±2.2). We cannot rule out the possibility that migraine patients suffering from headache more frequently exhibit a stronger alteration of the autonomic nervous system, but then it becomes almost impossible to obtain interictal recordings. As we only obtained a single interictal recording, it can also not be ruled out that autonomic function parameters and their reactivity to the paced breathing and mental stress tests change during the migraine cycle, as it was shown for the contingent negative variation (CNV)\[[@CR26]\]. The only significant difference between patients and controls in the present study was a slightly increased heart rate in patients over the two weeks interval. We showed that this was not due to increased heart rate during migraine attacks. However, because of frequent incapacitating headaches, migraine patients may also differ from controls in other factors not assessed in the present study, such as body mass index or physical training level. These factors might explain differences in heart rate, and should be considered in future studies.

Conclusion {#Sec16}
==========

The involvement of the autonomic nervous system in migraine pathophysiology is complex and heterogeneous. Numerous (but not all) published results suggest a sympathetic hyperactivation or parasympathetic hypoactivation. Our results point in the same direction with a slight difference in the balance between sympathetic and parasympathetic activation with a net increased sympathetic tone. Further long-term studies in a larger group of migraine patients will be needed to investigate heart rate variability parameters in migraine patients during daily routine and during all phases of the migraine cycle.

Ethics or institutional review board approval {#Sec17}
=============================================

The study was approved by the local ethics committee at the University of Munich (Project number: 133-13).Participants gave informed consent before taking part.

ANS

:   Autonomic nervous system

CNS

:   Central nervous system

ICHD

:   International classification of headache disorders

ECG

:   Electrocardiogram

HR

:   Heart rate

VC

:   Coefficient of variation

RMSSD

:   Root mean square of successive differences

VLF

:   Power in the very low-frequency band

LFN

:   Low-frequency noise

HFN

:   High-frequency noise; LF/HF ratio of LFN to HFN

E/I

:   Heart rate ratio between expiration and inspiration

SCL

:   Skin conductance latency

SPSS

:   Statistical package for social sciences

SD

:   Standard deviation

ANOVA

:   Analysis of variance

**Competing interests**

The authors declare that they have no competing interests.

**Authors' contributions**

VR conceived and designed the study, performed the experiments and the data analysis, drafted the initial manuscript and approved the final version of the manuscript. AS conceived and designed the study, revised the manuscript and gave approval of the final version of the manuscript. FS participated in the study design, programmed the paced breathing and mental stress test paradigm, revised the manuscript and gave approval of the final version of the manuscript. RR conceived and designed the study, supervised the experiments and the data analysis, revised the manuscript and gave approval of the final version of the manuscript. All authors read and approved the final manuscript.

We would like to thank all the participants in this study as well as Miss K. Ogston for her help in editing the manuscript. VR was supported by a grant from the DFG (GRK 1091).
